Tridek-One is a biotech start-up developing first-in-class CD31 agonist modalities designed to restore the immune balance.
- https://www.tridekone.com/
- Send an email
- Laurence de Schoulepnikoff
Tridek-One is a biotech start-up developing first-in-class CD31 agonist modalities designed to restore the immune balance.
Rue des Fontenailles 16, 1007 Lausanne, Switzerland